Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Investment Trends, Growth Opportunities, Challenges, and Future Perspectives
save 15 %
* Required Fields
Pay by invoice
The study is a comprehensive analysis of 30 most pressing patient safety adverse events affecting patients, care givers, and healthcare organizations across the globe. The study measures the current and forecast country-wise cost impact, number of incidences, and mortality of individual adverse events. It goes on to list the top adverse events, increasingly capturing care provider mind shares, current investment trends and forecast stakeholder interests. It also analyses the current competitive environment, most impactful vendor solutions addressing the top patient safety issues and their future market potential. The study also highlights some of the most innovative and promising solutions capable of disrupting the market as well as convergence of new technologies entering the field. It finally concludes with pointing out the top 5 most compelling future growth opportunities, key strategies for growth and implementation challenges.
Frost & Sullivan estimates that the various adverse events put an additional cost burden of $317.9 billion on hospitals across the US and Western Europe, adversely affecting 91.8 million patients and leading to 1.95 million deaths in 2016. The cost burden is expected to increase at a CAGR of 3.2% to reach $383.7 billion by 2022.
The various adverse events are segmented across four categories, namely
The study contains the following key data points with respect to an adverse event—
Market Assessment of Global Refurbished Medical Imaging Equipments
Integrated X-ray Fluoroscopy Market Analysis for Western Europe
Internet-delivered Therapies and Mobile Health Ushering a New Health Paradigm
Novel Technologies Driving Infectious Disease Management
Medical Device Innovations Furthering FemTech
Technologies Transforming the Biomanufacturing Landscape
Recent Innovations in Biopharmaceutical and Biomarker Technologies
Advancements in Gene Editing, Energy Harvesting, Biomimetics, and Wearable Devices
Fiducial Markers for Lung and Prostate Cancer in Europe and US, Forecast to 2022
Innovations in Digital Health, Biomanufacturing, Biopharmaceuticals, Genomics, and Diagnostics
natural gas market
biometric authentication market
digital signage market
solar cell market
packaged food industry
industrial robotics market
wound care market
dietary supplements market
diet food market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.